Summary
- Current Price
- As of today, TRVI price is $14.65, down -1.55% in the most recent trading session on
- Current Price All-Time High
- TRVI price is currently -9.12% below its historical high of $16.12 set on
- Market Cap
- TRVI current market cap is $2B, up +205.12% over the past 365 days
- PE Ratio
- TRVI PE ratio is unknown
- Revenue
- TRVI current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for TRVI is on
Profile
| Metric | Value |
|---|---|
| Full Name | Trevi Therapeutics, Inc. |
| Ticker | NASDAQ: TRVI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | trevitherapeutics.com |
| Employees | 31 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $14.65 | |
| Price, 1D Change | -1.55% | |
| $2B | ||
| - | ||
| - | ||
| 1.00 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.32 | ||
| EPS, 1Y Change | +32.46% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.32 | ||
| EPS Estimate | N/A | -$0.47 |
| EPS Est. Change | N/A | -48.57% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $14.65 | |
| Price Target | - | $23.00 |
| Price Tgt. Change | - | +57.00% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.48 | -$0.47 | +2.41% | |
| -$0.36 | -$0.32 | +12.66% | |
| -$0.47 | N/A | -48.57% | |
| -$0.52 | N/A | -65.14% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $14.65 | |
| $10.90 | ||
| SMA 200 vs Price | -25.59% | |
| $12.91 | ||
| SMA 50 vs Price | -11.91% | |
| 1.00 | ||
| $0.85 | ||
| 62.38 | ||
| 38.15% | ||
| 62.34% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.32 | ||
| -$132.00K | ||
| - | ||
| -$49.33M | ||
| - | ||
| -$42.76M | ||
| - | ||
| -$49.20M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 19.66 | ||
| 19.66 | ||
| - | ||
| - | ||
| 118.16 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 12.08 | ||
| -36.27 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $183.24M | ||
| $188.26M | ||
| $193.62M | ||
| $191.66M | ||
| $10.38M | ||
| $9.75M | ||
| $753.00K | ||
| $307.00K | ||
| $3.91M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $42.76M | ||
| $49.20M | ||
| $132.00K | ||
| $0.00 | ||
| $144.00K | ||
| $0.00 | ||
| -$64.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$42.09M | ||
| -$94.11M | ||
| $121.01M | ||
| $12.00K | ||
| -$42.10M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Needham | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| Jones Trading | → | |
| Needham | → | |
| Morgan Stanley | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with TRVI
FAQ
What is the ticker symbol for Trevi Therapeutics, Inc.?
The ticker symbol for Trevi Therapeutics, Inc. is NASDAQ:TRVI
Does Trevi Therapeutics, Inc. pay dividends?
No, Trevi Therapeutics, Inc. does not pay dividends
What sector is Trevi Therapeutics, Inc. in?
Trevi Therapeutics, Inc. is in the Healthcare sector
What industry is Trevi Therapeutics, Inc. in?
Trevi Therapeutics, Inc. is in the Biotechnology industry
What country is Trevi Therapeutics, Inc. based in?
Trevi Therapeutics, Inc. is headquartered in United States
When did Trevi Therapeutics, Inc. go public?
Trevi Therapeutics, Inc. initial public offering (IPO) was on May 7, 2019
Is Trevi Therapeutics, Inc. in the S&P 500?
No, Trevi Therapeutics, Inc. is not included in the S&P 500 index
Is Trevi Therapeutics, Inc. in the NASDAQ 100?
No, Trevi Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Trevi Therapeutics, Inc. in the Dow Jones?
No, Trevi Therapeutics, Inc. is not included in the Dow Jones index
When was Trevi Therapeutics, Inc. last earnings report?
Trevi Therapeutics, Inc.'s most recent earnings report was on May 5, 2026
When does Trevi Therapeutics, Inc. report earnings?
The next expected earnings date for Trevi Therapeutics, Inc. is August 6, 2026
Data Sources & References
- TRVI Official Website www.trevitherapeutics.com
- TRVI Profile on Yahoo Finance finance.yahoo.com/quote/TRVI
- TRVI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/trvi